Begin typing your search above and press return to search.
First Priority Will Be Given To TS In Covaxin: CM KCR
By: Tupaki Desk | 9 Sep 2020 2:00 PM GMT
Addressing the Telangana Assembly on the third day of the monsoon sessions, Telangana Rashtra Samithi,(TRS) Supremo, Chief Minister Kalvakuntla Chandrashekhar Rao made some sensational comments on the pandemic vaccine.
KCR said the government will make sure that Telangana will be given top priority in providing the potential vaccine to cure the ongoing pandemic as the vaccine is being manufactured by the drug development company Bharat Biotech that is based out of Hyderabad.
The Chief Minister maintained that after the drug manufacturer comes up with the potential vaccine, the state will get the priority.
He made these remarks while responding to the question asked by All India Majlis-e-Ittehadul Muslimeen (AIMIM) floor leader Akbaruddin Owaisi about handling the pandemic.
During the discussion on handling the pandemic crisis, AIMIM Leader showered praises on the efforts of Bharat Biotech.
Akbaruddin Owaisi mentioned that Bharat Biotech has kick-started the II Phase of clinical trails and said, once the vaccine is produced, the state should get its due share in the vaccine.
Covaxin, which is being developed by Bharat Biotech has entered the second phase of Clinical trials after getting its nod from the Centre. The vaccine is expected to be readied in early 2021.
KCR said the government will make sure that Telangana will be given top priority in providing the potential vaccine to cure the ongoing pandemic as the vaccine is being manufactured by the drug development company Bharat Biotech that is based out of Hyderabad.
The Chief Minister maintained that after the drug manufacturer comes up with the potential vaccine, the state will get the priority.
He made these remarks while responding to the question asked by All India Majlis-e-Ittehadul Muslimeen (AIMIM) floor leader Akbaruddin Owaisi about handling the pandemic.
During the discussion on handling the pandemic crisis, AIMIM Leader showered praises on the efforts of Bharat Biotech.
Akbaruddin Owaisi mentioned that Bharat Biotech has kick-started the II Phase of clinical trails and said, once the vaccine is produced, the state should get its due share in the vaccine.
Covaxin, which is being developed by Bharat Biotech has entered the second phase of Clinical trials after getting its nod from the Centre. The vaccine is expected to be readied in early 2021.
